What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.
about
A review on segmentation of positron emission tomography imagesImaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilitiesRepeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.Positron Emission Tomography (PET) in OncologyGradient-based delineation of the primary GTV on FLT PET in squamous cell cancer of the thoracic esophagus and impact on radiotherapy planning.Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinomaPretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapyMulti-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake timesStage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic FactorsDiffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic MonitoringState-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.A comparison of amplitude-based and phase-based positron emission tomography gating algorithms for segmentation of internal target volumes of tumors subject to respiratory motion.Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy.Prognostic value of metabolic tumor burden in lung cancer.The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinomaIndependent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.Current role of FDG PET/CT in lymphoma.PET/CT in therapy evaluation of patients with lung cancer.The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer.Functional imaging for radiotherapy treatment planning: current status and future directions-a review.Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions.Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics.Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer.Imaging for high-precision thoracic radiotherapy.Evaluation of PET/MRI for Tumor Volume Delineation for Head and Neck Cancer.Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.
P2860
Q26825470-35314119-5C0B-4659-9FF2-DB37F37834E6Q27025204-73BAA0B8-CD63-4214-AC15-38884CFF0C40Q30275817-C3BDB30E-05F0-48E8-923A-00C68BC2012EQ34774840-532C99A9-80F8-42AB-AA1B-F3F94A798BA1Q35092030-D73CFB90-F641-441A-A4DD-B41597AA9E20Q35096212-12F273D7-138D-4149-922B-D22C67AA34D7Q35474006-8BFDEC34-289C-4B44-ADBF-604DAA38C460Q35789209-4326A50D-F562-42BA-A991-72AC6518D5BEQ36282168-0E6DE1D3-F2C1-4F93-9429-3E1E9A5BAA55Q36304366-2E4D4F08-EC6C-494C-98AF-615F2D6A04B4Q36425348-B6C3876D-1073-426E-924A-D22A5F19597AQ37069297-E1125B86-B968-4168-8347-46AE3F890B44Q37144956-7538B62F-95BB-450C-8FEE-24356B679F10Q37180546-8A98E163-D34E-41FF-B173-0DC6C70785C4Q37226679-83464E12-A390-4BE4-B0E0-7D7E35E52F0AQ37354718-7B98CD92-5968-4726-B86E-98FFE1BF1D56Q37413672-D7738A6C-89EB-4BE5-94E4-40BC81155D55Q37433616-7A5D5969-4E69-45B5-86D9-5060CEC5B895Q37653213-A5DF62A0-6D8B-47DA-A515-D17DD5A5A059Q38014317-BE8F3D77-5339-46CA-9B86-56216EF21282Q38016163-6073AA75-B365-4998-9941-E061CF45DD8EQ38187365-14D0B6F7-9FCA-4073-890B-1A254147EFE8Q38202189-70A0EE20-313E-4FB7-8371-1A328E484D7EQ38262130-5FFD07AB-9CDF-4433-95CF-85F5558E0AF3Q38397651-907CD7E6-3406-436F-B1AF-DE4E32123FA6Q38766127-57DAFC9B-F456-4BC3-9076-18FDEA015986Q38925887-DC138569-C61F-4433-BAF1-8913AA7E79A5Q39793373-48E9642D-1DB1-46C7-B3E8-79A3B3703EF4Q40000698-BA608561-2C6E-4310-9BAE-C34C6ECE21B9Q40053178-63C11254-A83D-4B00-9231-19E971ADEA5AQ41677756-50BBA813-910A-47CB-A1ED-B36A171286C5Q41906868-C9FDD3F9-9DA6-497B-9987-56F0797FC363Q41998973-C71FCC20-FAE8-4FDA-8532-CA4D1CD55B4AQ43491287-1AEBA55C-E6E9-4A59-9BB4-DD8B89F729B8Q43526833-2EDF2031-B1B2-41C1-8E24-EC91C8E55129Q45065502-9F5CFC31-0CB5-41E0-92F3-A4EBF2051B3EQ45371931-2546986F-CDBA-4E5E-8372-C62B5B289BCEQ47135805-EC5FC983-8A4F-45FF-AD8E-746892DEBAE8Q47138202-A6EFC85A-46CA-483E-8687-988541A080B9Q47297629-0821EACA-9186-478F-9229-C55EDFF155AC
P2860
What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What is the best way to contou ...... g a NSCLC digital PET phantom.
@en
What is the best way to contou ...... g a NSCLC digital PET phantom.
@nl
type
label
What is the best way to contou ...... g a NSCLC digital PET phantom.
@en
What is the best way to contou ...... g a NSCLC digital PET phantom.
@nl
prefLabel
What is the best way to contou ...... g a NSCLC digital PET phantom.
@en
What is the best way to contou ...... g a NSCLC digital PET phantom.
@nl
P2093
P2860
P1476
What is the best way to contou ...... g a NSCLC digital PET phantom.
@en
P2093
Aaron S Nelson
Arden D Nelson
Fabio D Almeida
Jonathan W Piper
Kristin D Brockway
Nitin Ohri
Patrick Kang
Peter F Faulhaber
Walter Choi
P2860
P304
P356
10.1016/J.IJROBP.2010.12.055
P407
P577
2011-04-29T00:00:00Z